All lobbying filings

HOGAN LOVELLS US LLP

Lobbying for GRIFOLS SHARED SERVICES NORTH AMERICA, INC. · Biopharmaceutical company

Filing 4th Quarter - Termination

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $80,000.00 income · posted Jan 20, 2026

Official filing document

Bills named in this filing 5

HR 1476
PLASMA Act
S 694
PLASMA Act
HR 1143
Medicare IVIG Access Enhancement Act of 2025
HR 2343
John W. Walsh Alpha-1 Home Infusion Act of 2025
HR 2172
Preserving Patient Access to Home Infusion Act

Lobbying activity 2

Health Issues

H.R. 1476 & S. 694, Preserving Life-Saving Access to Specialty Medicines in America Act (Plasma Act), legislation to provide rebate phase-in for plasma-derived therapies under the Medicare Part D program. H.R. 1143, Medicare IVIG Access Enhancement Act of 2025. H.R. 2343 , John W. Walsh Alpha-1 Home Infusion Act of 2025. H.R. 2172, Preserving Patient Access to Home Infusion Act. Issues related to the implementation of P.L. 117-169, The Inflation Reduction Act.

Immigration

Issues related to immigration policy.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.